There was some great inputs and analysis from posters following the MRE update on February 4.
There is lots to look forward to over the next seven weeks, here are some of the upcoming catalysts for the remainder of the quarter:
• further drilling results, including greenfield
• update on Jambi (estimates of $0.30 plus per share)
• Scoping study (aims to increase the 0.5x NAV multiple)
• POX study (to lift payability to 100%)
• Ni price
The big one IMO is the scoping study. The Sprott report increased their valuation from $0.90 to $1.05 after applying a 50% discount factor to the NAV due to scopying study uncertainty, and a revised Ni price of $16,000.
By increasing the NAV multiple from 0.5x to 1.0x the valuation becomes $1.99.
Sprott report - February 4
Scoping Study
Add CTM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.010(2.56%) |
Mkt cap ! $197.9M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 40.0¢ | 38.0¢ | $790.9K | 1.998M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1320 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.0¢ | 12500 | 2 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
38.5¢ |
Change
0.010 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 39.0¢ | 39.0¢ | 38.0¢ | 82177 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| CTM (ASX) Chart |